May 24, 2019
Rose
The hearing is the first public trial to emerge from roughly 2,000 U.S. lawsuits aimed at holding drug companies accountable for their alleged role in the nation’s raging opioid crisis. “I expect a very spirited trial,” said local attorney and author Bob Burke. In other news on the epidemic: JPMorgan cuts ties with Purdue Pharma, the American Pain Society is considering filing for bankruptcy, and buprenorphine gains popularity as an addiction treatment.
from Kaiser Health News http://bit.ly/2X1Lgmw
May 24, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Even Doctors Can’t Navigate Our ‘Broken Health Care System’- CBO’s Report On Single-Payer Health Care Holds More Questions Than Answers
- Booker’s Argument For Environmental Justice Stays Within The Lines
- First Edition: May 2, 2019
- Relatively Unknown Secret Committees Have Been Influencing Insurers’ Drug Coverage Decisions For Decades
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment